Chemical Structure (Buprenorphine 01)
Buprenorphine Tablet
Product Images NDC 58118-0502
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 58118-0502). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Buprenorphine 02)
Buprenorphine Sl 8mg Tablet 30 Count Blister Card (Buprenorphine 04)
This is a description of Buprenorphine SL 8mg Tablets that are available for wholesale purposes. The NDC is 58118-0502-8 and the quantity is 30. The manufacturer's NDC is 42858-0502-03 7T GTIN is 0035818050289. It was manufactured by Rhodes Pharmaceuticals and expires in 2023 Oct. It was produced in Coventry, RI, USA, and has the SN YYMMDD00000O. The Ropaciod is being sold by Clinical Solutions Wholesale. The address is 416 Mary Linguay Pk O, S 519-ok-TN 37067 USA, and the Lot # is SAMPLE123 and Batch # is SAMPLEAS6.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
